Hugh O'Neill

Hugh O'Neill has worked in the field of data analysis and software validation since 2002. Hugh began their career at Pfizer, where they held the roles of GLP Systems Lead, Operations Manager (Drug Safety), and Technology Services Manager. In 2012, they took a Consultancy Project with Shire Pharmaceuticals and began working as a Consultant for Croft Data Analysis Ltd. In 2013, they took a Consultancy Project with the Medical Research Council. In 2014, they began working as a Business Analyst for Cancer Research UK, where they specialized in BA and acted as the Quality Manager for various projects. In 2016, they took a Consultancy Project with Imanova Limited, Imperial College, Hammersmith Hospital in London. In 2017, they took a role as Consultancy Services with CALIGOR OPCO UK, LTD. In 2018, they began working as a Director of Quality and Operations and a Consultant for PHARMASEAL. Finally, in 2019, they took a Consultant role with Takeda and in 2020 they began working as a Consultant - Business Analysis and Software Validation for Cancer Research UK (CRUK).

Hugh O'Neill received their PhD in Computational Drug Design from Liverpool School of Pharmacy in 1989. Prior to this, they obtained a BSc (HONS) in Applied Biology from Liverpool John Moores University in 1985.